EasyDNNNews

Wednesday, March 22, 2017

Ultrasound Findings at Mid-Neoadjuvant Treatment of Breast Cancer May Be Associated with RCB Among Patients with TNBC and HR-Negative, HER2-Positive Disease

Cancer Therapy Advisor (3/21, Primeau) reports that research indicated “ultrasound findings at mid-neoadjuvant (NAC) treatment of breast cancer were associated with residual cancer burden (RCB) among patients with triple-negative breast cancer (TNBC) and hormone receptor (HR)-negative, HER2-positive disease.” The findings were published in The Oncologist. 

Print
0 Comments

Categories: 2017, March, News, Research and CareNumber of views: 6684

Tags:

Theme picker